Journal Article
. 1996 Mar; 271(9):5251-7.
doi: 10.1074/jbc.271.9.5251.

All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired

J Baulida 1 M H Kraus  M Alimandi  P P Di Fiore  G Carpenter  
  • PMID: 8617810
  •     134 citations


Four transmembrane tyrosine kinases constitute the ErbB receptor family: the epidermal growth factor (EGF) receptor, ErbB-2, ErbB-3, and ErbB-4. We have measured the endocytic capacities of all four members of the EGF receptor family, including ErbB-3 and ErbB-4, which have not been described previously. EGF-responsive chimeric receptors containing the EGF receptor extracellular domain and different ErbB cytoplasmic domains (EGFR/ErbB) have been employed. The capacity of these growth factor-receptor complexes to mediate 125I-EGF internalization, receptor down-regulation, receptor degradation, and receptor co-immunoprecipitation with AP-2 was assayed. In contrast to the EGF receptor, all EGFR/ErbB receptors show impaired ligand-induced rapid internalization, down-regulation, degradation, and AP-2 association. Also, we have analyzed the heregulin-responsive wild-type ErbB-4 receptor, which does not mediate the rapid internalization of 125I-heregulin, demonstrates no heregulin-regulated receptor degradation, and fails to form association complexes with AP-2. Despite the substantial differences in ligand-induced receptor trafficking between the EGF and ErbB-4 receptors, EGF and heregulin have equivalent capacities to stimulate DNA synthesis in quiescent cells. These results show that the ligand-dependent down-regulation mechanism of the EGF receptor, surprisingly, is not a property of any other known ErbB receptor family member. Since endocytosis is thought to be an attenuation mechanism for growth factor-receptor complexes, these data imply that substantial differences in attenuation mechanisms exist within one family of structurally related receptors.

Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development.
Q S Ji, G E Winnier, +4 authors, G Carpenter.
Proc Natl Acad Sci U S A, 1997 Apr 01; 94(7). PMID: 9096335    Free PMC article.
Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors.
R A Anders, S L Arline, J J Doré, E B Leof.
Mol Biol Cell, 1997 Nov 15; 8(11). PMID: 9362058    Free PMC article.
Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism.
M Vecchi, G Carpenter.
J Cell Biol, 1997 Dec 31; 139(4). PMID: 9362517    Free PMC article.
Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts.
Q S Ji, S Ermini, +2 authors, G Carpenter.
Mol Biol Cell, 1998 May 16; 9(4). PMID: 9529375    Free PMC article.
Cell-specific viral targeting mediated by a soluble retroviral receptor-ligand fusion protein.
S Snitkovsky, J A Young.
Proc Natl Acad Sci U S A, 1998 Jun 17; 95(12). PMID: 9618539    Free PMC article.
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.
A E Lenferink, R Pinkas-Kramarski, +7 authors, Y Yarden.
EMBO J, 1998 Jun 17; 17(12). PMID: 9628875    Free PMC article.
ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner.
M A Olayioye, D Graus-Porta, +3 authors, N E Hynes.
Mol Cell Biol, 1998 Aug 26; 18(9). PMID: 9710588    Free PMC article.
Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network.
E Tzahar, J D Moyer, +9 authors, Y Yarden.
EMBO J, 1998 Oct 17; 17(20). PMID: 9774339    Free PMC article.
Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo.
S Grimm, E J Weinstein, I M Krane, P Leder.
J Exp Med, 1998 Oct 23; 188(8). PMID: 9782131    Free PMC article.
Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation.
Z Wang, L Zhang, T K Yeung, X Chen.
Mol Biol Cell, 1999 May 08; 10(5). PMID: 10233167    Free PMC article.
The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.
H Waterman, I Alroy, +2 authors, Y Yarden.
EMBO J, 1999 Jun 16; 18(12). PMID: 10369675    Free PMC article.
Intracellular movement of green fluorescent protein-tagged phosphatidylinositol 3-kinase in response to growth factor receptor signaling.
H Gillham, M C Golding, R Pepperkok, W J Gullick.
J Cell Biol, 1999 Aug 25; 146(4). PMID: 10459020    Free PMC article.
Stimulation of beta1-integrin function by epidermal growth factor and heregulin-beta has distinct requirements for erbB2 but a similar dependence on phosphoinositide 3-OH kinase.
M A Adelsman, J B McCarthy, Y Shimizu.
Mol Biol Cell, 1999 Sep 03; 10(9). PMID: 10473632    Free PMC article.
The oncogenic 70Z Cbl mutation blocks the phosphotyrosine binding domain-dependent negative regulation of ZAP-70 by c-Cbl in Jurkat T cells.
J E van Leeuwen, P K Paik, L E Samelson.
Mol Cell Biol, 1999 Sep 22; 19(10). PMID: 10490604    Free PMC article.
Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.
S K Muthuswamy, M Gilman, J S Brugge.
Mol Cell Biol, 1999 Sep 22; 19(10). PMID: 10490623    Free PMC article.
Highly Cited.
Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.
P Nagy, A Jenei, +2 authors, J Szölôsi.
Pathol Oncol Res, 1999 Dec 23; 5(4). PMID: 10607920
c-erbB-4 protein expression in human breast cancer.
T Y Kew, J A Bell, +6 authors, I O Ellis.
Br J Cancer, 2000 Mar 29; 82(6). PMID: 10735500    Free PMC article.
The ErbB signaling network: receptor heterodimerization in development and cancer.
M A Olayioye, R M Neve, H A Lane, N E Hynes.
EMBO J, 2000 Jul 06; 19(13). PMID: 10880430    Free PMC article.
Highly Cited. Review.
ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.
R Pinkas-Kramarski, I Alroy, Y Yarden.
J Mammary Gland Biol Neoplasia, 1997 Apr 01; 2(2). PMID: 10882296
Hormonal regulation of type I receptor tyrosine kinase expression in the mammary gland.
M De Bortoli, C Dati.
J Mammary Gland Biol Neoplasia, 1997 Apr 01; 2(2). PMID: 10882303
Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.
K L Carraway, C A Carraway, K L Carraway.
J Mammary Gland Biol Neoplasia, 1997 Apr 01; 2(2). PMID: 10882304
Inhibition of ErbB-2 mitogenic and transforming activity by RALT, a mitogen-induced signal transducer which binds to the ErbB-2 kinase domain.
L Fiorentino, C Pertica, +6 authors, O Segatto.
Mol Cell Biol, 2000 Sep 26; 20(20). PMID: 11003669    Free PMC article.
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases.
D F Stern.
Breast Cancer Res, 2001 Mar 16; 2(3). PMID: 11250707    Free PMC article.
A novel 14-kilodalton protein interacts with the mitogen-activated protein kinase scaffold mp1 on a late endosomal/lysosomal compartment.
W Wunderlich, I Fialka, +5 authors, L A Huber.
J Cell Biol, 2001 Mar 27; 152(4). PMID: 11266467    Free PMC article.
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.
Y Ito, T Takeda, +6 authors, N Matsuura.
Br J Cancer, 2001 May 18; 84(10). PMID: 11355950    Free PMC article.
Regulation of epidermal growth factor receptor signaling by endocytosis and intracellular trafficking.
P Burke, K Schooler, H S Wiley.
Mol Biol Cell, 2001 Jun 16; 12(6). PMID: 11408594    Free PMC article.
Highly Cited.
Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members.
M A Olayioye.
Breast Cancer Res, 2001 Dec 12; 3(6). PMID: 11737890    Free PMC article.
PKB-mediated negative feedback tightly regulates mitogenic signalling via Gab2.
Danielle K Lynch, Roger J Daly.
EMBO J, 2002 Jan 10; 21(1-2). PMID: 11782427    Free PMC article.
An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels.
A John Diamonti, Pamela M Guy, +3 authors, Kermit L Carraway.
Proc Natl Acad Sci U S A, 2002 Feb 28; 99(5). PMID: 11867753    Free PMC article.
Selective targeting and inducible destruction of human cancer cells by retroviruses with envelope proteins bearing short peptide ligands.
Timothy J Gollan, Michael R Green.
J Virol, 2002 Mar 09; 76(7). PMID: 11884581    Free PMC article.
ErbB-4: a receptor tyrosine kinase.
W Zhou, G Carpenter.
Inflamm Res, 2002 Apr 03; 51(2). PMID: 11926320
Dominant negative knockout of p53 abolishes ErbB2-dependent apoptosis and permits growth acceleration in human breast cancer cells.
G C Huang, S Hobbs, M Walton, R J Epstein.
Br J Cancer, 2002 Apr 16; 86(7). PMID: 11953857    Free PMC article.
The role of the ubiquitination-proteasome pathway in breast cancer: ubiquitin mediated degradation of growth factor receptors in the pathogenesis and treatment of cancer.
Stan Lipkowitz.
Breast Cancer Res, 2003 Feb 01; 5(1). PMID: 12559039    Free PMC article.
A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.
Mariko Hatakeyama, Shuhei Kimura, +9 authors, Akihiko Konagaya.
Biochem J, 2003 Apr 15; 373(Pt 2). PMID: 12691603    Free PMC article.
Profiling receptor tyrosine kinase activation by using Ab microarrays.
Ulrik B Nielsen, Mike H Cardone, +2 authors, Peter K Sorger.
Proc Natl Acad Sci U S A, 2003 Jul 24; 100(16). PMID: 12876202    Free PMC article.
An integrated model of epidermal growth factor receptor trafficking and signal transduction.
Haluk Resat, Jonathan A Ewald, David A Dixon, H Steven Wiley.
Biophys J, 2003 Jul 30; 85(2). PMID: 12885624    Free PMC article.
HER2-mediated effects on EGFR endosomal sorting: analysis of biophysical mechanisms.
Bart S Hendriks, H Steven Wiley, Douglas Lauffenburger.
Biophys J, 2003 Sep 26; 85(4). PMID: 14507736    Free PMC article.
Negative regulation of ErbB family receptor tyrosine kinases.
C Sweeney, K L Carraway.
Br J Cancer, 2004 Jan 22; 90(2). PMID: 14735165    Free PMC article.
Association with membrane protrusions makes ErbB2 an internalization-resistant receptor.
Anette M Hommelgaard, Mads Lerdrup, Bo van Deurs.
Mol Biol Cell, 2004 Jan 27; 15(4). PMID: 14742716    Free PMC article.
Endocytosis and sorting of ErbB2 and the site of action of cancer therapeutics trastuzumab and geldanamycin.
Cary D Austin, Ann M De Mazière, +5 authors, Richard H Scheller.
Mol Biol Cell, 2004 Sep 24; 15(12). PMID: 15385631    Free PMC article.
Highly Cited.
Synergistic growth inhibition by Iressa and Rapamycin is modulated by VHL mutations in renal cell carcinoma.
R M Gemmill, M Zhou, +3 authors, H A Drabkin.
Br J Cancer, 2005 Jun 16; 92(12). PMID: 15956968    Free PMC article.
Anti-erbB-2 antibody trastuzumab in the treatment of HER2-amplified breast cancer.
Christina H Yeon, Mark D Pegram.
Invest New Drugs, 2005 Sep 01; 23(5). PMID: 16133791
Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
Caren V Lund, Mikhail Popkov, Laurent Magnenat, Carlos F Barbas.
Mol Cell Biol, 2005 Oct 04; 25(20). PMID: 16199884    Free PMC article.
The extracellular region of ErbB4 adopts a tethered conformation in the absence of ligand.
Samuel Bouyain, Patti A Longo, +2 authors, Daniel J Leahy.
Proc Natl Acad Sci U S A, 2005 Oct 06; 102(42). PMID: 16203964    Free PMC article.
The inhibitory effect of ErbB2 on epidermal growth factor-induced formation of clathrin-coated pits correlates with retention of epidermal growth factor receptor-ErbB2 oligomeric complexes at the plasma membrane.
Camilla Haslekås, Kamilla Breen, +3 authors, Inger Helene Madshus.
Mol Biol Cell, 2005 Oct 07; 16(12). PMID: 16207817    Free PMC article.
FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion.
Naciba Benlimame, Qiang He, +5 authors, Moulay A Alaoui-Jamali.
J Cell Biol, 2005 Nov 09; 171(3). PMID: 16275754    Free PMC article.
Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
Chengfeng Yang, Ying Liu, Mark A Lemmon, Marcelo G Kazanietz.
Mol Cell Biol, 2006 Jan 24; 26(3). PMID: 16428439    Free PMC article.
HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
Cindy A Wilson, Elaina E Cajulis, +6 authors, Dennis J Slamon.
Breast Cancer Res, 2006 Feb 07; 7(6). PMID: 16457687    Free PMC article.
Modeling the effects of HER/ErbB1-3 coexpression on receptor dimerization and biological response.
Harish Shankaran, H Steven Wiley, Haluk Resat.
Biophys J, 2006 Mar 15; 90(11). PMID: 16533841    Free PMC article.
Modulation of integrin-linked kinase (ILK) expression in human oesophageal squamous cell carcinoma cell lines by the EGF and TGFbeta1 growth factors.
Glenn A Driver, Robin B Veale.
Cancer Cell Int, 2006 Apr 29; 6. PMID: 16643659    Free PMC article.
Endosomal receptor kinetics determine the stability of intracellular growth factor signalling complexes.
A Rami Tzafriri, Elazer R Edelman.
Biochem J, 2006 Nov 23; 402(3). PMID: 17117924    Free PMC article.
Neuregulin-induced ErbB3 downregulation is mediated by a protein stability cascade involving the E3 ubiquitin ligase Nrdp1.
Zhongwei Cao, Xiuli Wu, +2 authors, Kermit L Carraway.
Mol Cell Biol, 2007 Jan 11; 27(6). PMID: 17210635    Free PMC article.
Stimulated ErbB4 internalization is necessary for neuregulin signaling in neurons.
Yu Liu, Yan-Mei Tao, +2 authors, Lin Mei.
Biochem Biophys Res Commun, 2007 Jan 26; 354(2). PMID: 17250808    Free PMC article.
The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis.
M M Moasser.
Oncogene, 2007 May 02; 26(45). PMID: 17471238    Free PMC article.
Highly Cited. Review.
Regulation of ErbB-4 endocytosis by neuregulin in GABAergic hippocampal interneurons.
M Longart, M Chatani-Hinze, +2 authors, A Buonanno.
Brain Res Bull, 2007 Jun 15; 73(4-6). PMID: 17562386    Free PMC article.
Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness.
Charles S Cobbs, Liliana Soroceanu, +4 authors, Matthias H Kraus.
J Neurooncol, 2007 Jun 26; 85(3). PMID: 17589804
Endocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.
Mads Lerdrup, Silas Bruun, +4 authors, Bo van Deurs.
Mol Biol Cell, 2007 Jul 13; 18(9). PMID: 17626164    Free PMC article.
Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.
Marc R Birtwistle, Mariko Hatakeyama, +3 authors, Boris N Kholodenko.
Mol Syst Biol, 2007 Nov 16; 3. PMID: 18004277    Free PMC article.
Highly Cited.
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.
Kristina W Thiel, Graham Carpenter.
Proc Natl Acad Sci U S A, 2007 Nov 29; 104(49). PMID: 18042729    Free PMC article.
The epidermal growth factor receptor family: biology driving targeted therapeutics.
M J Wieduwilt, M M Moasser.
Cell Mol Life Sci, 2008 Feb 09; 65(10). PMID: 18259690    Free PMC article.
Highly Cited. Review.
Endocytic downregulation of ErbB receptors: mechanisms and relevance in cancer.
Kirstine Roepstorff, Lene Grøvdal, +2 authors, Bo van Deurs.
Histochem Cell Biol, 2008 Feb 22; 129(5). PMID: 18288481    Free PMC article.
Epidermal growth factor receptor and cancer: control of oncogenic signalling by endocytosis.
Michael Vibo Grandal, Inger Helene Madshus.
J Cell Mol Med, 2008 Mar 06; 12(5A). PMID: 18318691    Free PMC article.
Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms.
Maria Sundvall, Anna Korhonen, +5 authors, Klaus Elenius.
Proc Natl Acad Sci U S A, 2008 Mar 13; 105(11). PMID: 18334649    Free PMC article.
Topological analysis of MAPK cascade for kinetic ErbB signaling.
Takashi Nakakuki, Noriko Yumoto, +3 authors, Mariko Hatakeyama.
PLoS One, 2008 Mar 13; 3(3). PMID: 18335053    Free PMC article.
The ERBB3 receptor in cancer and cancer gene therapy.
G Sithanandam, L M Anderson.
Cancer Gene Ther, 2008 Apr 12; 15(7). PMID: 18404164    Free PMC article.
Mechanisms of ErbB receptor negative regulation and relevance in cancer.
William H D Fry, Lakmal Kotelawala, Colleen Sweeney, Kermit L Carraway.
Exp Cell Res, 2008 Aug 19; 315(4). PMID: 18706412    Free PMC article.
Clathrin-independent endocytosis of ErbB2 in geldanamycin-treated human breast cancer cells.
Daniel J Barr, Anne G Ostermeyer-Fay, Rachel A Matundan, Deborah A Brown.
J Cell Sci, 2008 Sep 04; 121(Pt 19). PMID: 18765569    Free PMC article.
A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells.
Srikumar M Raja, Robert J Clubb, +8 authors, Hamid Band.
Cancer Biol Ther, 2008 Sep 05; 7(10). PMID: 18769124    Free PMC article.
Endocytosis and intracellular trafficking of ErbBs.
Alexander Sorkin, Lai Kuan Goh.
Exp Cell Res, 2008 Sep 17; 314(17). PMID: 18793634    Free PMC article.
Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells.
Fenghua Zeng, Jie Xu, Raymond C Harris.
FASEB J, 2009 Feb 06; 23(6). PMID: 19193720    Free PMC article.
Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis.
Tsipi Ben-Kasus, Bilha Schechter, +2 authors, Michael Sela.
Proc Natl Acad Sci U S A, 2009 Feb 17; 106(9). PMID: 19218427    Free PMC article.
Systems biological analysis of epidermal growth factor receptor internalization dynamics for altered receptor levels.
Hannah Schmidt-Glenewinkel, Eileen Reinz, Roland Eils, Nathan R Brady.
J Biol Chem, 2009 Mar 20; 284(25). PMID: 19297331    Free PMC article.
Nuclisome: a novel concept for radionuclide therapy using targeting liposomes.
Amelie Fondell, Katarina Edwards, +3 authors, Lars Gedda.
Eur J Nucl Med Mol Imaging, 2009 Aug 08; 37(1). PMID: 19662408
Human epidermal growth factor receptor dimerization analysis in breast cancer diagnosis: potential for improving testing accuracy and treatment selection.
Melanie Spears, John M S Bartlett.
Mol Diagn Ther, 2009 Nov 21; 13(6). PMID: 19925033
Interactions between anti-ErbB2 antibody A21 and the ErbB2 extracellular domain provide a basis for improving A21 affinity.
Liang Chang, Changhai Zhou, Man Xu, Jing Liu.
J Comput Aided Mol Des, 2009 Dec 17; 24(1). PMID: 20012671
The constitutive activity of epidermal growth factor receptor vIII leads to activation and differential trafficking of wild-type epidermal growth factor receptor and erbB2.
Reema Zeineldin, Yan Ning, Laurie G Hudson.
J Histochem Cytochem, 2010 Feb 18; 58(6). PMID: 20159766    Free PMC article.
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells.
Luisa Paris, Serena Cecchetti, +7 authors, Franca Podo.
Breast Cancer Res, 2010 May 14; 12(3). PMID: 20462431    Free PMC article.
E3 ubiquitin ligases in ErbB receptor quantity control.
Kermit L Carraway.
Semin Cell Dev Biol, 2010 Sep 28; 21(9). PMID: 20868762    Free PMC article.
Therapeutic strategies and mechanisms of tumorigenesis of HER2-overexpressing breast cancer.
Anna Emde, Wolfgang J Köstler, Yosef Yarden, Association of Radiotherapy and Oncology of the Mediterranean arEa (AROME).
Crit Rev Oncol Hematol, 2010 Oct 19; 84 Suppl 1. PMID: 20951604    Free PMC article.
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab.
Toni M Brand, Mari Iida, Deric L Wheeler.
Cancer Biol Ther, 2011 Feb 05; 11(9). PMID: 21293176    Free PMC article.
Structural insights into the down-regulation of overexpressed p185(her2/neu) protein of transformed cells by the antibody chA21.
Huihao Zhou, Zhao Zha, +9 authors, Jing Liu.
J Biol Chem, 2011 Jun 18; 286(36). PMID: 21680730    Free PMC article.
p21-activated kinases in Erbb2-positive breast cancer: A new therapeutic target?
Luis E Arias-Romero, Jonathan Chernoff.
Small GTPases, 2011 Jun 21; 1(2). PMID: 21686266    Free PMC article.
AAK1 identified as an inhibitor of neuregulin-1/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics.
Letian Kuai, Shao-En Ong, +11 authors, Stephen J Haggarty.
Chem Biol, 2011 Aug 02; 18(7). PMID: 21802010    Free PMC article.
Targeting 4-1BB costimulation to disseminated tumor lesions with bi-specific oligonucleotide aptamers.
Fernando Pastor, Despina Kolonias, James O McNamara, Eli Gilboa.
Mol Ther, 2011 Aug 11; 19(10). PMID: 21829171    Free PMC article.
Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding.
Laura B Kleiman, Thomas Maiwald, +2 authors, Peter K Sorger.
Mol Cell, 2011 Sep 03; 43(5). PMID: 21884975    Free PMC article.
Molecular Mechanisms that Regulate Epidermal Growth Factor Receptor Inactivation.
Brian P Ceresa, Phillip A Vanlandingham.
Clin Med Oncol, 2008 Jan 01; 2. PMID: 21892266    Free PMC article.
Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.
Xue-Qin Yang, Chuang Chen, +7 authors, Yan Li.
Int J Nanomedicine, 2011 Nov 11; 6. PMID: 22072864    Free PMC article.
The peptide derived from erbB2 auto-inhibitor herstatin shared in the same epitope and function with functional antibody 2C4.
Ming Lv, Chunxia Qiao, +6 authors, Beifen Shen.
Mol Biotechnol, 2011 Dec 06; 51(2). PMID: 22139885
Treatment of vestibular schwannoma cells with ErbB inhibitors.
Matthew L Bush, Sarah S Burns, +4 authors, Abraham Jacob.
Otol Neurotol, 2012 Jan 10; 33(2). PMID: 22222570    Free PMC article.
EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.
Kristy J Wilson, Christopher Mill, +7 authors, David J Riese.
Growth Factors, 2012 Jan 21; 30(2). PMID: 22260327    Free PMC article.
Endocytosis and signaling: cell logistics shape the eukaryotic cell plan.
Sara Sigismund, Stefano Confalonieri, +3 authors, Pier Paolo Di Fiore.
Physiol Rev, 2012 Feb 03; 92(1). PMID: 22298658    Free PMC article.
Highly Cited. Review.
In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Christel Larbouret, Nadège Gaborit, +7 authors, André Pèlegrin.
Neoplasia, 2012 Mar 21; 14(2). PMID: 22431920    Free PMC article.
Epidermal growth factor cytoplasmic domain affects ErbB protein degradation by the lysosomal and ubiquitin-proteasome pathway in human cancer cells.
Aleksandra Glogowska, Jörg Stetefeld, +3 authors, Thomas Klonisch.
Neoplasia, 2012 Jun 30; 14(5). PMID: 22745586    Free PMC article.
The tanapoxvirus 15L protein is a virus-encoded neuregulin that promotes viral replication in human endothelial cells.
David Jeng, Zhenzhong Ma, +3 authors, Karim Essani.
J Virol, 2012 Dec 28; 87(6). PMID: 23269801    Free PMC article.
Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors.
Maren Schwenke, Martin Knöfler, +7 authors, Birgit Gellersen.
PLoS One, 2013 Jan 26; 8(1). PMID: 23349855    Free PMC article.
Identification of caveolin-1 as a potential causative factor in the generation of trastuzumab resistance in breast cancer cells.
Sreeja C Sekhar, Tomonari Kasai, +8 authors, Masaharu Seno.
J Cancer, 2013 Jul 09; 4(5). PMID: 23833684    Free PMC article.
HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).
James J Sollome, Elangovan Thavathiru, Todd D Camenisch, Richard R Vaillancourt.
Cell Signal, 2013 Sep 17; 26(1). PMID: 24036211    Free PMC article.
Growth factor signaling and memory formation: temporal and spatial integration of a molecular network.
Ashley M Kopec, Thomas J Carew.
Learn Mem, 2013 Sep 18; 20(10). PMID: 24042849    Free PMC article.
Endocytosis and cancer.
Ira Mellman, Yosef Yarden.
Cold Spring Harb Perspect Biol, 2013 Dec 04; 5(12). PMID: 24296170    Free PMC article.
Highly Cited. Review.
HER2 monoclonal antibodies that do not interfere with receptor heterodimerization-mediated signaling induce effective internalization and represent valuable components for rational antibody-drug conjugate design.
Bart E C G de Goeij, Matthias Peipp, +8 authors, Paul W H I Parren.
MAbs, 2014 Feb 05; 6(2). PMID: 24492309    Free PMC article.
Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
Smita Awasthi, Anne W Hamburger.
J Cell Physiol, 2014 Apr 03; 229(11). PMID: 24692179    Free PMC article.
When Good Turns Bad: Regulation of Invasion and Metastasis by ErbB2 Receptor Tyrosine Kinase.
Ditte Marie Brix, Knut Kristoffer Bundgaard Clemmensen, Tuula Kallunki.
Cells, 2014 Apr 09; 3(1). PMID: 24709902    Free PMC article.
Challenges in the Treatment of Triple Negative and HER2-Overexpressing Breast Cancer.
L Alexis Hoeferlin, Charles E Chalfant, Margaret A Park.
J Surg Sci, 2014 May 13; 1(1). PMID: 24818173    Free PMC article.
The Mysterious Ways of ErbB2/HER2 Trafficking.
Vibeke Bertelsen, Espen Stang.
Membranes (Basel), 2014 Aug 08; 4(3). PMID: 25102001    Free PMC article.
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells.
Tameka A Bailey, Haitao Luan, +9 authors, Hamid Band.
J Biol Chem, 2014 Sep 17; 289(44). PMID: 25225290    Free PMC article.
Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
Sandra Dupouy, Van Kien Doan, +8 authors, Patricia Forgez.
Oncotarget, 2014 Sep 25; 5(18). PMID: 25249538    Free PMC article.
Role of Erbin in ErbB2-dependent breast tumor growth.
Yanmei Tao, Chengyong Shen, +13 authors, Lin Mei.
Proc Natl Acad Sci U S A, 2014 Oct 08; 111(42). PMID: 25288731    Free PMC article.
A HER2-specific Modified Fc Fragment (Fcab) Induces Antitumor Effects Through Degradation of HER2 and Apoptosis.
Kin-Mei Leung, Sarah Batey, +16 authors, Haijun Sun.
Mol Ther, 2015 Aug 04; 23(11). PMID: 26234505    Free PMC article.
Scale-up of a physiologically-based pharmacokinetic model to predict the disposition of monoclonal antibodies in monkeys.
Patrick M Glassman, Yang Chen, Joseph P Balthasar.
J Pharmacokinet Pharmacodyn, 2015 Sep 14; 42(5). PMID: 26364301
The EGFR-HER2 module: a stem cell approach to understanding a prime target and driver of solid tumors.
M R Schneider, Y Yarden.
Oncogene, 2015 Oct 06; 35(23). PMID: 26434585    Free PMC article.
The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
Zaklina Kovacevic, Sharleen V Menezes, +4 authors, Des R Richardson.
J Biol Chem, 2015 Nov 05; 291(3). PMID: 26534963    Free PMC article.
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR.
S Ingthorsson, K Andersen, +3 authors, T Gudjonsson.
Oncogene, 2015 Dec 22; 35(32). PMID: 26686087    Free PMC article.
Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.
Raymond Reif, Alshaimaa Adawy, +6 authors, Jan G Hengstler.
J Biol Chem, 2016 Jan 01; 291(8). PMID: 26719328    Free PMC article.
Marked enhancement of lysosomal targeting and efficacy of ErbB2-targeted drug delivery by HSP90 inhibition.
Srikumar M Raja, Swapnil S Desale, +10 authors, Hamid Band.
Oncotarget, 2016 Feb 10; 7(9). PMID: 26859680    Free PMC article.
Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.
Christina M Campion, Sandra Leon Carrion, +3 authors, Judith A Cole.
Chem Biol Interact, 2016 Apr 28; 253. PMID: 27117977    Free PMC article.
Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.
Patrick M Glassman, Joseph P Balthasar.
J Pharmacokinet Pharmacodyn, 2016 Jul 06; 43(4). PMID: 27377311
Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.
Gabriella Mincione, Maria Carmela Di Marcantonio, +8 authors, Raffaella Muraro.
Oncotarget, 2016 Nov 02; 7(46). PMID: 27732953    Free PMC article.
The Contribution of Spatial and Temporal Molecular Networks in the Induction of Long-term Memory and Its Underlying Synaptic Plasticity.
Anastasios A Mirisis, Anamaria Alexandrescu, Thomas J Carew, Ashley M Kopec.
AIMS Neurosci, 2016 Nov 08; 3(3). PMID: 27819030    Free PMC article.
ERBB3: A potential serum biomarker for early detection and therapeutic target for devil facial tumour 1 (DFT1).
Dane A Hayes, Dale A Kunde, +3 authors, Elizabeth T Snow.
PLoS One, 2017 Jun 08; 12(6). PMID: 28591206    Free PMC article.
A Novel Signaling Complex between TROY and EGFR Mediates Glioblastoma Cell Invasion.
Zonghui Ding, Alison Roos, +6 authors, Joseph C Loftus.
Mol Cancer Res, 2017 Nov 10; 16(2). PMID: 29117939    Free PMC article.
Emerging functions of the EGFR in cancer.
Sara Sigismund, Daniele Avanzato, Letizia Lanzetti.
Mol Oncol, 2017 Nov 11; 12(1). PMID: 29124875    Free PMC article.
Highly Cited. Review.
Composite regulation of ERK activity dynamics underlying tumour-specific traits in the intestine.
Yu Muta, Yoshihisa Fujita, +7 authors, Masamichi Imajo.
Nat Commun, 2018 Jun 07; 9(1). PMID: 29872037    Free PMC article.
SORLA regulates endosomal trafficking and oncogenic fitness of HER2.
Mika Pietilä, Pranshu Sahgal, +15 authors, Johanna Ivaska.
Nat Commun, 2019 May 30; 10(1). PMID: 31138794    Free PMC article.
HER2-Targeted PET Imaging and Therapy of Hyaluronan-Masked HER2-Overexpressing Breast Cancer.
Patricia M R Pereira, Ashwin Ragupathi, +3 authors, Jason S Lewis.
Mol Pharm, 2019 Dec 06; 17(1). PMID: 31804840    Free PMC article.
Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines.
Yuanhui Liu, Claire Calmel, +3 authors, Françoise Praz.
J Cell Mol Med, 2020 Jun 10; 24(14). PMID: 32515546    Free PMC article.
Anti-EGFR therapy in metastatic colorectal cancer: mechanisms and potential regimens of drug resistance.
Qing-Hai Li, Ying-Zhao Wang, +7 authors, Jin-Ning Ye.
Gastroenterol Rep (Oxf), 2020 Jul 16; 8(3). PMID: 32665850    Free PMC article.
The deubiquitylase USP2 maintains ErbB2 abundance via counteracting endocytic degradation and represents a therapeutic target in ErbB2-positive breast cancer.
Jinrui Zhang, Shuyan Liu, +13 authors, Han Liu.
Cell Death Differ, 2020 Apr 25; 27(9). PMID: 32327714    Free PMC article.
Preclinical Characteristics of the Irreversible Pan-HER Kinase Inhibitor Neratinib Compared with Lapatinib: Implications for the Treatment of HER2-Positive and HER2-Mutated Breast Cancer.
Denis M Collins, Neil T Conlon, +4 authors, John Crown.
Cancers (Basel), 2019 May 31; 11(6). PMID: 31141894    Free PMC article.
Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles.
Esteban Cruz, Veysel Kayser.
Cancers (Basel), 2019 Jun 27; 11(6). PMID: 31234432    Free PMC article.
Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics.
Anatoly Kiyatkin, Iris K van Alderwerelt van Rosenburgh, Daryl E Klein, Mark A Lemmon.
Sci Signal, 2020 Aug 21; 13(645). PMID: 32817373    Free PMC article.
Coordinated dysregulation of cancer progression by the HER family and p21-activated kinases.
Rakesh Kumar, Aswathy Mary Paul, +2 authors, M Radhakrishna Pillai.
Cancer Metastasis Rev, 2020 Aug 21; 39(3). PMID: 32820388
Neuregulins in Neurodegenerative Diseases.
Guan-Yong Ou, Wen-Wen Lin, Wei-Jiang Zhao.
Front Aging Neurosci, 2021 Apr 27; 13. PMID: 33897409    Free PMC article.
A Phase I Study of Alpelisib in Combination with Trastuzumab and LJM716 in Patients with PIK3CA-Mutated HER2-Positive Metastatic Breast Cancer.
Komal Jhaveri, Joshua Z Drago, +10 authors, Shanu Modi.
Clin Cancer Res, 2021 May 06; 27(14). PMID: 33947692    Free PMC article.
Nrg1β Released in Remote Ischemic Preconditioning Improves Myocardial Perfusion and Decreases Ischemia/Reperfusion Injury via ErbB2-Mediated Rescue of Endothelial Nitric Oxide Synthase and Abrogation of Trx2 Autophagy.
Venkatesh Kundumani-Sridharan, Jaganathan Subramani, Cade Owens, Kumuda C Das.
Arterioscler Thromb Vasc Biol, 2021 May 28; 41(8). PMID: 34039018    Free PMC article.